CCL · NYSE
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $26.62B | $25.02B | $21.59B | $12.17B | $1.91B | $5.59B | $20.82B | $18.88B |
| Cost of Revenue | — | $15.64B | $14.32B | $11.76B | $4.66B | — | $12.91B | $11.09B |
| Selling, General & Administrative | $3.40B | $3.25B | $2.95B | $2.52B | $1.89B | $1.88B | $2.48B | $2.45B |
| Operating Expenses | — | $21.45B | $19.64B | $16.55B | $9.00B | $14.46B | $17.55B | $15.56B |
| Operating Income | $4.48B | $3.57B | $1.96B | -$4.38B | -$7.09B | -$8.87B | $3.28B | $3.33B |
| Interest Expense | — | — | $2.07B | $1.61B | $1.60B | $895.00M | $206.00M | $194.00M |
| Other Income / (Expense) | -$4.00M | -$1.66B | -$2.02B | -$1.70B | -$2.43B | -$1.39B | -$215.00M | -$118.00M |
| Income Before Taxes | $2.77B | $1.92B | -$62.00M | -$6.08B | -$9.52B | -$10.25B | $3.06B | $3.21B |
| Provision for Income Taxes | $12.00M | -$1.00M | $13.00M | $14.00M | -$21.00M | -$17.00M | $71.00M | $54.00M |
| Net Income | $2.76B | $1.92B | -$74.00M | -$6.09B | -$9.50B | -$10.24B | $2.99B | $3.15B |
| Basic EPS | $2.10 | $1.50 | -$0.06 | -$5.16 | -$8.46 | -$13.20 | $4.34 | $4.45 |
| Diluted EPS | $2.02 | $1.44 | -$0.06 | -$5.16 | -$8.46 | -$13.20 | $4.32 | $4.44 |
| Basic Shares Outstanding | 1.31B | 1.27B | 1.26B | 1.18B | 1.12B | 775.00M | 690.00M | 709.00M |
| Diluted Shares Outstanding | 1.40B | 1.40B | 1.26B | 1.18B | 1.12B | 775.00M | 692.00M | 710.00M |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Nov 2026 | $2.23 | $2.20 | $2.26 | 7 | ↑0 ↓0 |
| Nov 2027 | $2.59 | $2.51 | $2.66 | 9 | ↑0 ↓2 |
| Nov 2028 | $2.94 | $2.88 | $3.06 | 4 | ↑2 ↓0 |
| Nov 2029 | $3.37 | $3.37 | $3.37 | 1 | ↑0 ↓0 |